Search Results - "Sheu, Wayne H. H."

Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study by Seino, Yutaka, Kim, Dae Jung, Yabe, Daisuke, Tan, Elise Chia‐Hui, Chung, Wook‐Jin, Ha, Kyoung Hwa, Nangaku, Masaomi, Node, Koichi, Klement, Riho, Yasui, Atsutaka, Lei, Wei‐Yu, Lee, Sunwoo, Kyaw, Moe H., Deruaz‐Luyet, Anouk, Brodovicz, Kimberly G., H.‐H. Sheu, Wayne

“…Aim To evaluate the effectiveness of empagliflozin in clinical practice in East Asia in the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) East…”
Get full text

Higher fasting glucose is associated with poorer survival in non-diabetic subjects having ischemia with non-obstructive coronary arteries by Liang, Kae-Woei, Sheu, Wayne H.-H., Lee, Wen-Jane, Wang, Jun-Sing, Lee, Wen-Lieng

“…Subjects who have ischemia with non-obstructive coronary arteries (INOCA) experience angina pectoris with evidence of myocardial ischemia but without coronary…”
Get full text

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide by Gerstein, Hertzel C., Colhoun, Helen M., Dagenais, Gilles R., Diaz, Rafael, Lakshmanan, Mark, Pais, Prem, Probstfield, Jeffrey, Riddle, Matthew C., Rydén, Lars, Xavier, Denis, Atisso, Charles M., Avezum, Alvaro, Basile, Jan, Chung, Namsik, Conget, Ignacio, Cushman, William C., Franek, Edward, Hancu, Nicolae, Hanefeld, Markolf, Holt, Shaun, Jansky, Petr, Keltai, Matyas, Lanas, Fernando, Leiter, Lawrence A., Lopez‐Jaramillo, Patricio, Cardona‐Munoz, Ernesto G., Pirags, Valdis, Pogosova, Nana, Raubenheimer, Peter J., Shaw, Jonathan, Sheu, Wayne H‐H., Temelkova‐Kurktschiev, Theodora

“…The aim was to determine the effects of dulaglutide, a synthetic once‐weekly, injectable human glucagon‐like peptide 1 analogue that lowers blood glucose, body…”
Get full text

Prevalence and prognosis of genetically proven familial hypercholesterolemia in subjects with coronary artery disease and reduced ejection fraction by Lee, Wen-Jane, Chuang, Han-Ni, Hsiao, Tzu-Hung, Lee, Wen-Lieng, Wu, Jen-Pey, Sheu, Wayne H.-H., Liang, Kae-Woei

“…Few studies have genetically screened variants related to familial hypercholesterolemia (FH) and investigated their survival impact in patients with coronary…”
Get full text

Electronic dashboard‐based remote glycemic management program reduces length of stay and readmission rate among hospitalized adults by Sheen, Yi‐Jing, Huang, Chien‐Chung, Huang, Shih‐Che, Lin, Ching‐Heng, Lee, I‐Te, H‐H Sheu, Wayne

“…Aims/Introduction Currently, the impact of hospital‐wide glycemic control interventions on length of hospital stay (LOS) and readmission rates are largely…”
Get full text

Glycemic variability and diabetes retinopathy: A missing link by Hsu, Cherng-Ru, Chen, Yu-Tsung, Sheu, Wayne H.-H

“…Abstract Daily glucose variability, such as fasting plasma glucose fluctuation or postprandial hyperglycemia, has been proposed as contributors to…”
Get full text

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial by Bain, Stephen C., Mosenzon, Ofri, Arechavaleta, Rosario, Bogdański, Pawel, Comlekci, Abdurrahman, Consoli, Agostino, Deerochanawong, Chaicharn, Dungan, Kathleen, Faingold, Maria C., Farkouh, Michael E., Franco, Denise R., Gram, Jeppe, Guja, Cristian, Joshi, Pankaj, Malek, Rachid, Merino‐Torres, Juan F., Nauck, Michael A., Pedersen, Sue D., Sheu, Wayne H. ‐H., Silver, Robert J., Tack, Cees J., Tandon, Nikhil, Jeppesen, Ole K., Strange, Mette, Thomsen, Mette, Husain, Mansoor

“…Aims To assess the cardiovascular (CV) safety of oral semaglutide, the first tablet formulation of a glucagon‐like peptide‐1 receptor agonist. Materials and…”
Get full text

Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations by Deerochanawong, Chaicharn, Chan, Siew P., Matawaran, Bien J., Sheu, Wayne H.‐H., Chan, Juliana, Man, Nguyen H., Suastika, Ketut, Khoo, Chin M., Yoon, Kun‐Ho, Luk, Andrea, Mithal, Ambrish, Linong, Ji

“…Diabetes mellitus in Asia accounts for more than half of the global prevalence. There is a high prevalence of cardiovascular disease (CVD) in the region among…”
Get full text

Accuracy of Point-of-Care Blood Glucometers in Neonates and Critically Ill Adults by Sheen, Yi-Jing, Wang, Jiunn-Min, Tsai, Pi-fen, Lee, Wen-Jane, Hsu, Ya-Chi, Wang, Chen-Yu, Sheu, Wayne H.-H.

“…Inpatient glycemic management has become a common issue because of the increasing number of hospitalized patients with hyperglycemia. Point-of-care devices can…”
Get full text

HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance by Chuang, Huai-Chia, Sheu, Wayne H. -H., Lin, Yi-Ting, Tsai, Ching-Yi, Yang, Chia-Yu, Cheng, Yu-Jhen, Huang, Pau-Yi, Li, Ju-Pi, Chiu, Li-Li, Wang, Xiaohong, Xie, Min, Schneider, Michael D., Tan, Tse-Hua

“…Proinflammatory cytokines play important roles in insulin resistance. Here we report that mice with a T-cell-specific conditional knockout of HGK (T-HGK cKO)…”
Get full text

Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes by Sheu, Wayne H-H, Gantz, Ira, Chen, Menghui, Suryawanshi, Shailaja, Mirza, Arpana, Goldstein, Barry J, Kaufman, Keith D, Engel, Samuel S

“…This study was conducted to determine the optimal dose of omarigliptin, a once-weekly (q.w.) dipeptidyl peptidase IV (DPP-4) inhibitor, for the treatment of…”
Get full text

Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database by Weng, Jianping, Soegondo, Sidartawan, Schnell, Oliver, Sheu, Wayne H.-H., Grzeszczak, Wladyslaw, Watada, Hirotaka, Yamamoto, Noriyuki, Kalra, Sanjay

“…Background Alpha‐glucosidase inhibitors are recommended in some international guidelines as first‐line, second‐line and third‐line treatment options but are…”
Get full text

Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis by Sheu, Wayne H.-H, Brunell, Steven C, Blase, Erich

“…Highlights • The characteristics of T2DM are different among Asian and White patients. • Data on whether clinical practice should differ between ethnic groups…”
Get full text

Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan by Yu, Neng-Chun, Su, Hsiu-Yueh, Chiou, Shu-Ti, Yeh, Mei Chang, Yeh, Sheau-Wen, Tzeng, Min-Su, Sheu, Wayne H.-H

“…Abstract Aims To understand the trends of ABC control in 5 years interval in Taiwan. Methods We compared two waves of nationwide surveys ( n = 7541 and n =…”
Get full text

Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data pool by Schnell, Oliver, Weng, Jianping, Sheu, Wayne H.-H, Watada, Hirotaka, Kalra, Sanjay, Soegondo, Sidartawan, Yamamoto, Noriyuki, Rathod, Rahul, Zhang, Cheryl, Grzeszczak, Wladyslaw

“…Abstract Objective The objective of this study is to examine the effect of acarbose, an alpha-glucosidase inhibitor, on body weight in a real-life setting by…”
Get full text

Real‐world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register by Kong, Alice P. S., Lew, Thomas, Lau, Eric S. H., Lim, Lee‐Ling, Kesavadev, Jothydev, Jia, Weiping, Sheu, Wayne H.‐H., Sobrepena, Leorino, Tan, Alexander T. B., Nguyen, Thy Khue, Yoon, Kun‐Ho, Wang, Ke, Kodiappan, Kamlanathan, Treuer, Tamás, Chan, Juliana C. N.

“…Aims To explore the pattern of insulin use and glycaemic control in Asian people with type 2 diabetes, stratified by gender, young‐onset diabetes (YOD;…”
Get full text

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes by Gerstein, Hertzel C., Ramasundarahettige, Chinthanie, Avezum, Alvero, Basile, Jan, Conget, Ignacio, Cushman, William C., Dagenais, Gilles R., Franek, Edward, Lakshmanan, Mark, Lanas, Fernando, Leiter, Lawrence A., Pogosova, Nana, Probstfield, Jeffrey, Raubenheimer, Peter J., Riddle, Matthew, Shaw, Jonathan, Sheu, Wayne H.-H., Temelkova-Kurktschiev, Theodora, Turfanda, Ibrahim, Xavier, Denis

“…Abstract Background The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A…”
Get full text

Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways by Chang, Chun-Yu, Shen, Chao-Yu, Kang, Chao-Kai, Sher, Yuh-Pyng, Sheu, Wayne H.-H., Chang, Chia-Che, Lee, Tsung-Han

“…Oxidized LDL (oxLDL) induces a pro-oxidative environment and promotes apoptosis, causing the progression of renal diseases in humans. Taurine is a…”
Get full text

Diabetes and shoulder disorders by Hsu, Cherng‐Lan, Sheu, Wayne H‐H

“…Multivariate Cox proportional hazards models were used to explore the effect of: (i) diabetes; (ii) hyperlipidemia; (iii) diabetes with/without insulin use;…”
Get full text

Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring by Wang, J.-S., Tu, S.-T., Lee, I.-T., Lin, S.-D., Lin, S.-Y., Su, S.-L., Lee, W.-J., Sheu, Wayne H.-H.

“…Background Previous studies examining the contributions of fasting glucose (FG) and postprandial glucose (PPG) to glycated haemoglobin ($\hbox{HbA}_{{\rm…”
Get full text